Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Study of Two Dose Levels of Privigen in Pediatric CIDP

NCT03684018 is registered in ClinicalTrials.gov with CSL Behring as lead sponsor.

NCT NCT03684018
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03684018 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Study of Two Dose Levels of Privigen in Pediatric CIDP
Lead sponsor
CSL Behring
Phase
Phase 4
Overall status
Recruiting
Start date
February 28, 2019
Completion date
December 20, 2029
Enrollment
30 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

pediatric chronic inflammatory demyelinating polyneuropathy (cidp)